Berry Genomics Co Ltd Cash Flow Conversion Efficiency
Berry Genomics Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Berry Genomics Co Ltd (000710) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.18 Million ≈ $-319.41K USD) by net assets (CN¥1.65 Billion ≈ $241.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Berry Genomics Co Ltd (1998–2024)
Cash flow conversion efficiency of Berry Genomics Co Ltd from 1998 to 2024. This chart illustrates how Berry Genomics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000710 stock price and chart for real-time trading data and today's change.
Berry Genomics Co Ltd Cash Flow Conversion Ratio Explained
Berry Genomics Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Berry Genomics Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Berry Genomics Co Ltd ranked by their cash flow conversion efficiency. Also see 000710 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Suzhou Sonavox Electronics Co. Ltd. A
SHG:688533
|
0.090x |
|
Zhejiang Natural Outdoor Goods Inc.
SHG:605080
|
N/A |
|
Poly Union Chemical Holding Group Co Ltd
SHE:002037
|
0.023x |
|
Wirtualna Polska Holding SA
WAR:WPL
|
0.127x |
|
Invesco California Value Muni Inc Tr
NYSE:VCV
|
0.018x |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
0.105x |
|
Colorlight Cloud Tech Ltd. A
SHE:301391
|
N/A |
|
Sichuan Zhongguang Lightning Protection Technologies Co Ltd
SHE:300414
|
0.005x |
Annual Cash Flow Conversion Efficiency for Berry Genomics Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Berry Genomics Co Ltd from 1998 to 2024. Review Berry Genomics Co Ltd (000710) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.72 Billion ≈ $250.98 Million |
CN¥87.97 Million ≈ $12.87 Million |
0.051x | -12.46% |
| 2023-12-31 | CN¥1.89 Billion ≈ $277.24 Million |
CN¥111.01 Million ≈ $16.24 Million |
0.059x | +544.41% |
| 2022-12-31 | CN¥2.33 Billion ≈ $340.85 Million |
CN¥21.18 Million ≈ $3.10 Million |
0.009x | -75.60% |
| 2021-12-31 | CN¥2.52 Billion ≈ $369.30 Million |
CN¥94.03 Million ≈ $13.76 Million |
0.037x | -44.05% |
| 2020-12-31 | CN¥2.42 Billion ≈ $354.48 Million |
CN¥161.31 Million ≈ $23.60 Million |
0.067x | +27.01% |
| 2019-12-31 | CN¥2.35 Billion ≈ $343.45 Million |
CN¥123.06 Million ≈ $18.01 Million |
0.052x | -38.40% |
| 2018-12-31 | CN¥1.94 Billion ≈ $284.22 Million |
CN¥165.33 Million ≈ $24.19 Million |
0.085x | +78.65% |
| 2017-12-31 | CN¥1.56 Billion ≈ $228.34 Million |
CN¥74.35 Million ≈ $10.88 Million |
0.048x | +138.30% |
| 2016-12-31 | CN¥114.08 Million ≈ $16.69 Million |
CN¥-14.19 Million ≈ $-2.08 Million |
-0.124x | +79.32% |
| 2015-12-31 | CN¥117.69 Million ≈ $17.22 Million |
CN¥-70.81 Million ≈ $-10.36 Million |
-0.602x | -513.72% |
| 2014-12-31 | CN¥130.03 Million ≈ $19.03 Million |
CN¥18.91 Million ≈ $2.77 Million |
0.145x | +12.60% |
| 2013-12-31 | CN¥121.00 Million ≈ $17.71 Million |
CN¥15.63 Million ≈ $2.29 Million |
0.129x | -66.90% |
| 2012-12-31 | CN¥123.68 Million ≈ $18.10 Million |
CN¥48.27 Million ≈ $7.06 Million |
0.390x | +322.78% |
| 2011-12-31 | CN¥122.50 Million ≈ $17.93 Million |
CN¥-21.46 Million ≈ $-3.14 Million |
-0.175x | -128.10% |
| 2010-12-31 | CN¥122.22 Million ≈ $17.89 Million |
CN¥76.19 Million ≈ $11.15 Million |
0.623x | +3165.21% |
| 2009-12-31 | CN¥114.51 Million ≈ $16.76 Million |
CN¥-2.33 Million ≈ $-340.79K |
-0.020x | -103.67% |
| 2008-12-31 | CN¥104.34 Million ≈ $15.27 Million |
CN¥57.76 Million ≈ $8.45 Million |
0.554x | +1012.22% |
| 2007-12-31 | CN¥94.51 Million ≈ $13.83 Million |
CN¥4.70 Million ≈ $688.23K |
0.050x | -57.48% |
| 2006-12-31 | CN¥99.78 Million ≈ $14.60 Million |
CN¥11.68 Million ≈ $1.71 Million |
0.117x | +52.21% |
| 2005-12-31 | CN¥98.59 Million ≈ $14.43 Million |
CN¥7.58 Million ≈ $1.11 Million |
0.077x | +234.93% |
| 2004-12-31 | CN¥112.75 Million ≈ $16.50 Million |
CN¥-6.43 Million ≈ $-940.18K |
-0.057x | -420.11% |
| 2003-12-31 | CN¥112.11 Million ≈ $16.41 Million |
CN¥-1.23 Million ≈ $-179.74K |
-0.011x | -108.00% |
| 2002-12-31 | CN¥108.87 Million ≈ $15.93 Million |
CN¥14.91 Million ≈ $2.18 Million |
0.137x | +125.90% |
| 2001-12-31 | CN¥161.48 Million ≈ $23.63 Million |
CN¥-85.39 Million ≈ $-12.50 Million |
-0.529x | -1232.97% |
| 2000-12-31 | CN¥207.06 Million ≈ $30.30 Million |
CN¥-8.21 Million ≈ $-1.20 Million |
-0.040x | -157.27% |
| 1999-12-31 | CN¥220.90 Million ≈ $32.33 Million |
CN¥15.30 Million ≈ $2.24 Million |
0.069x | -48.25% |
| 1998-12-31 | CN¥211.44 Million ≈ $30.94 Million |
CN¥28.30 Million ≈ $4.14 Million |
0.134x | -- |
About Berry Genomics Co Ltd
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcri… Read more